NEWEarnings
DexCom (DXCM) Trading at $64.62 with P/E Ratios 30.92 and 25.91
Published on 4/26/2026

AI Summary
DexCom, Inc. (DXCM) shares traded at $64.62 as of April 20th. The company reported trailing and forward P/E ratios of 30.92 and 25.91, respectively. DexCom has achieved an average revenue growth of 17.4% annually over the past three years, with projections suggesting 15.2% growth ahead. The launch of the Stelo over-the-counter CGM and the G7 15-day sensor is expected to expand the market and improve gross margins to 63-64%, potentially increasing user retention and capturing millions of new insured lives. DexCom is targeting aggressive growth in international markets, particularly in Western Europe, Japan, and Australia.
Related News

Markets
NIKE (NKE) Stock Analysis: P/E Ratio 30.58 with Current Value at $46.48
Apr 26

Markets
Airbnb (ABNB) Stock Analysis: Key Insights on Buy Potential
Apr 26

Earnings
U.S. Bancorp (USB) Maintains Strong P/E Ratio at 11.95 and 11.34
Apr 26

Earnings
Western Alliance Bancorporation (WAL) Evaluates Strong Valuation Metrics
Apr 26